Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585 Buy
+3
New +$622 ﹤0.01% 654
2025
Q2
Sell
-73
Closed -$16.3K 676
2025
Q1
$16.3K Buy
+73
New +$17K ﹤0.01% 389
2024
Q1
Sell
-1
Closed -$172 766
2023
Q4
$172 Hold
1
﹤0.01% 700
2023
Q3
$148 Sell
1
-2
-67% -$362 ﹤0.01% 775
2023
Q2
$656 Buy
+3
New +$669 ﹤0.01% 823
2021
Q1
Sell
-11
Closed -$2K 765
2020
Q4
$2K Hold
11
﹤0.01% 695
2020
Q3
$2K Hold
11
﹤0.01% 602
2020
Q2
$2K Hold
11
﹤0.01% 560
2020
Q1
$2K Buy
+11
New +$1.75K ﹤0.01% 558
2019
Q3
Sell
-23
Closed -$3K 702
2019
Q2
$3K Buy
+23
New +$2.55K ﹤0.01% 774

Other funds holding RMD

MOTCO's RMD Position: Q2 2026 in Review

MOTCO opened a new position in ResMed (RMD) in Q2 2026: 3 shares worth $585. The stake represents ﹤0.01% of the portfolio and ranks #654 among its holdings. This is a return to the name: MOTCO previously reported a position in RMD as recently as Q1 2025.

MOTCO first reported a position in RMD in Q2 2019 and has held it in 10 quarters since. The position peaked at $16.3K in Q1 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • MOTCO held 3 shares of ResMed worth $585 as of Q2 2026.
  • ResMed was a new MOTCO position in Q2 2026.
  • ResMed made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #654 holding.
  • MOTCO first reported a position in ResMed in Q2 2019 and has held it in 10 quarters since.
  • MOTCO's ResMed position peaked at $16.3K in Q1 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.